Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

582
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
582
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

478
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
478
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

619
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
619
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

511
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
511
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

534
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
534
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

443
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
443

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baseline PaO2 Modifies the Impact of Oxygenator Use in Temporary Right Ventricular Assist Device Support: A Multicenter Propensity-Weighted Analysis.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Evaluation of dual-lumen pulmonary artery cannulation in extracorporeal right ventricular support.

JTCVS open·2026
Same author

Genome and Transcriptome-Wide Analyses Identify Multiple Candidate Genes and a Significant Polygenic Contribution in Bicuspid Aortic Valve.

Circulation·2026
Same author

Pirfenidone to prevent fibrosis in acute respiratory distress syndrome: The PIONEER study protocol.

Contemporary clinical trials·2025
Same author

Extent of surgical repair and outcomes after surgery for type A aortic dissection.

BJS open·2025
Same author

PLACE: Multicenter Study for Right Ventricular Failure on Mechanical Cardiocirculatory Supports.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2025

Related Experiment Video

Updated: Apr 25, 2026

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

1.3K

Medical management in type B aortic dissection.

Toru Suzuki1, Kim A Eagle1, Eduardo Bossone1

  • 11 The University of Tokyo, Tokyo, Japan ; 2 University of Michigan, Ann Arbor, MI, USA ; 3 Cardiology Division, "Cava de' Tirreni and Amalfi Coast" Hospital, Heart Department, University of Salerno, Italy ; 4 IRCCS Policlinico San Donato, San Donato Milanese, Italy ; 5 Massachusetts General Hospital, Boston, MA, USA.

Annals of Cardiothoracic Surgery
|August 19, 2014
PubMed
Summary

Medical management, primarily using antihypertensive drugs, is standard for uncomplicated acute aortic dissection. Current treatment lacks robust evidence, but new research hints at type-specific medication benefits.

Keywords:
Aortic dissectionmedication

More Related Videos

Complete and Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Hemorrhagic Shock
06:30

Complete and Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Hemorrhagic Shock

Published on: May 19, 2022

10.5K
Balloon-based Injury to Induce Myointimal Hyperplasia in the Mouse Abdominal Aorta
07:32

Balloon-based Injury to Induce Myointimal Hyperplasia in the Mouse Abdominal Aorta

Published on: February 7, 2018

8.9K

Related Experiment Videos

Last Updated: Apr 25, 2026

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

1.3K
Complete and Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Hemorrhagic Shock
06:30

Complete and Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Hemorrhagic Shock

Published on: May 19, 2022

10.5K
Balloon-based Injury to Induce Myointimal Hyperplasia in the Mouse Abdominal Aorta
07:32

Balloon-based Injury to Induce Myointimal Hyperplasia in the Mouse Abdominal Aorta

Published on: February 7, 2018

8.9K

Area of Science:

  • Cardiology
  • Vascular Surgery
  • Internal Medicine

Background:

  • Uncomplicated type B acute aortic dissection typically receives medical management.
  • Antihypertensive agents are central to treatment, reducing stress on the aorta.
  • Current management relies on expert opinion and observational data due to a lack of randomized controlled trials.

Purpose of the Study:

  • To review the current understanding of medical management for acute aortic dissection.
  • To highlight the evidence gaps and evolving therapeutic strategies.

Main Methods:

  • Review of existing literature and guidelines.
  • Discussion of current medical management principles and drug selection.

Main Results:

  • Medical management, focused on antihypertensives, is the standard approach.
  • Guidelines exist but acknowledge limited evidence for specific treatments.
  • Emerging data suggests potential type-selective benefits of antihypertensive medications.

Conclusions:

  • Despite established guidelines, evidence for optimal medical management of acute aortic dissection remains limited.
  • Further research, including randomized controlled trials, is needed to refine therapeutic strategies.
  • Type-selective antihypertensive therapy may offer future benefits in managing acute aortic dissection.